Javascript must be enabled to continue!
Lead as a toxic environmental toxicant in models of synucleinopathies
View through CrossRef
AbstractLead, a toxic heavy metal, is prevalent in various industrial applications, contributing to environmental contamination and significant health concerns. Lead affects various body systems, especially the brain, causing long-lasting cognitive and behavioral changes. While most studies have focused on continuous lead exposure, intermittent exposure, such as that caused by migration or relocations, has received less attention. Importantly, lead exposure intensifies the severity of Parkinson’s disease (PD) and dementia with Lewy bodies, diseases involving the accumulation of alpha-synuclein (aSyn) in the brain and in the gut. Although, the precise mechanisms underlying these observations remain unclear, oxidative stress and mitochondrial dysfunction likely play a role. Here, we investigated how two different profiles of lead exposure - continuous and intermittent - affect models of synucleinopathies. We found that lead exposure enhances the formation of aSyn inclusions, resulting in an increase in both their number and size in cell models. In addition, we found that animals injected with aSyn pre-formed fibrils display serine 129-phosphorylated aSyn inclusions and a reduction in astrocytes in the substantia nigra. These animals also display neuronal damage and alterations in locomotor activity, exploratory behavior, anxiety, memory impairments and hypertension. Our results suggest a mechanistic link between environmental lead exposure and the onset and progression of diseases associated with aSyn pathology. Understanding the molecular and cellular interactions between lead and aSyn is crucial for shaping public health policies and may provide novel insight into strategies for mitigating the impact of environmental toxins on neurodegenerative processes involved in Parkinson’s disease and related synucleinopathies.Key points summaryLead exposure increases the number and size of alpha-synuclein (aSyn) inclusions in cell models.∼Animals exposed to aSyn fibrils and lead show increased phosphorylation of aSyn, neuronal damage and reduced astrogliosis in thesubstantia nigra.Lead-exposed animals exhibit impaired locomotion, anxiety, memory deficits, hypertension and chemoreceptor reflex hypersensitivity.The study suggests a mechanistic link between environmental lead exposure and the progression of diseases involving aSyn pathology, such as Parkinson’s disease.
Cold Spring Harbor Laboratory
Title: Lead as a toxic environmental toxicant in models of synucleinopathies
Description:
AbstractLead, a toxic heavy metal, is prevalent in various industrial applications, contributing to environmental contamination and significant health concerns.
Lead affects various body systems, especially the brain, causing long-lasting cognitive and behavioral changes.
While most studies have focused on continuous lead exposure, intermittent exposure, such as that caused by migration or relocations, has received less attention.
Importantly, lead exposure intensifies the severity of Parkinson’s disease (PD) and dementia with Lewy bodies, diseases involving the accumulation of alpha-synuclein (aSyn) in the brain and in the gut.
Although, the precise mechanisms underlying these observations remain unclear, oxidative stress and mitochondrial dysfunction likely play a role.
Here, we investigated how two different profiles of lead exposure - continuous and intermittent - affect models of synucleinopathies.
We found that lead exposure enhances the formation of aSyn inclusions, resulting in an increase in both their number and size in cell models.
In addition, we found that animals injected with aSyn pre-formed fibrils display serine 129-phosphorylated aSyn inclusions and a reduction in astrocytes in the substantia nigra.
These animals also display neuronal damage and alterations in locomotor activity, exploratory behavior, anxiety, memory impairments and hypertension.
Our results suggest a mechanistic link between environmental lead exposure and the onset and progression of diseases associated with aSyn pathology.
Understanding the molecular and cellular interactions between lead and aSyn is crucial for shaping public health policies and may provide novel insight into strategies for mitigating the impact of environmental toxins on neurodegenerative processes involved in Parkinson’s disease and related synucleinopathies.
Key points summaryLead exposure increases the number and size of alpha-synuclein (aSyn) inclusions in cell models.
∼Animals exposed to aSyn fibrils and lead show increased phosphorylation of aSyn, neuronal damage and reduced astrogliosis in thesubstantia nigra.
Lead-exposed animals exhibit impaired locomotion, anxiety, memory deficits, hypertension and chemoreceptor reflex hypersensitivity.
The study suggests a mechanistic link between environmental lead exposure and the progression of diseases involving aSyn pathology, such as Parkinson’s disease.
Related Results
Neuropathology, Genetics and Biomarkers of Synucleinopathies
Neuropathology, Genetics and Biomarkers of Synucleinopathies
Abstract
Synucleinopathies are clinically and pathologically heterogeneous disorders characterized by pathologic aggregates of α-synuclein in neurons and glia, in the form ...
Enhancing sleep quality in synucleinopathies through physical exercise
Enhancing sleep quality in synucleinopathies through physical exercise
During sleep, several crucial processes for brain homeostasis occur, including the rearrangement of synaptic connections, which is essential for memory formation and updating. Slee...
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
Alpha-synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), are a class of neurodegenerative diseases. A diagnosi...
Gut Microbiota, Plasma Metabolites, and Synucleinopathies: A Mendelian Randomization Study
Gut Microbiota, Plasma Metabolites, and Synucleinopathies: A Mendelian Randomization Study
introduction:
Certain observational studies have indicated a link between gut microbiota, metabolites, and synucleinopathies, but the causal relationship mediat...
Reference Toxicants in Quality Control of Aquatic Bioassays
Reference Toxicants in Quality Control of Aquatic Bioassays
Use of a reference toxicant promises to improve the usefulness of toxicity tests. Criteria such as <10 percent mortality during a pretest acclimation period indicate only th...
Nutrient Regulation of Relative Dominance of Cylindrospermopsin-Producing and Non-cylindrospermopsin-Producing Raphidiopsis raciborskii
Nutrient Regulation of Relative Dominance of Cylindrospermopsin-Producing and Non-cylindrospermopsin-Producing Raphidiopsis raciborskii
Raphidiopsis raciborskii (previously Cylindrospermopsis raciborskii) can produce cylindrospermopsin (CYN) which is of great concern due to its considerable toxicity to human and an...
Saving the Planet with Barbie?
Saving the Planet with Barbie?
In 2019, Mattel introduced a series of Barbie dolls in connection with National Geographic which included a Polar Marine Biologist, an Entomologist, a Wildlife Photojournalist, and...
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Synucleinopathies are a set of devastating neurodegenerative diseases that share a pathologic accumulation of the protein α-synuclein (α-syn). This accumulation causes neuronal dea...

